Back to Trades
Kayyem Jon Faiz
DirectorCIK 0001366268
Profile
- Filings
- 3
- Buy transactions
- 2
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Kayyem Jon Faiz, Director, has filed 3 SEC reports (2026), all concentrated in Inhibrx Biosciences, Inc. (INBX), totaling $2.5M in disclosed volume. Weighing $1.1M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $567.6K in Inhibrx Biosciences, Inc.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Sep 17 | INBX Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Buy | $500.0K |
| Sep 8 | INBX Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Buy | $567.6K |
| Jun 4 | INBX Inhibrx Biosciences, Inc. | Kayyem Jon Faiz | Director | Award | $1.4M |
3 filings